LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Nobel Prize Winner Runs Marathons
People In The News

Nobel Prize Winner Runs Marathons

October 31, 2012 1 min read Premium comments

Advertisement

Nobel Prize Winner Runs Marathons
Shinya Yamanaka

Shinya Yamanaka, the scientist who won this year’s Nobel Prize for developing induced pluripotent stem cells (iPS), is also an athlete. Yamanaka ran in this year’s Tokyo Marathon in March to raise money for basic iPS research and covered the distance in 4 hours 3 minutes 19 seconds. He is scheduled to run again in the second Osaka Marathon on November 25.

As a high school student Yamanaka practiced judo, breaking one or two bones a year. His friends say that those experiences prompted him to pursue a career in sports medicine and eventually to study iPS cells.

“He was aggressive when it came to judo, ” said Soichi Tanaka, 50, a fellow member of Yamanaka’s high school judo club. “Today he makes steady efforts in his research—the same attitude he already had in those days.” He added that Yanaka was basically a gentle person.

Yanaka also played rugby. Yukihito Hasunuma, a 51-year-old doctor who was one of Yamanaka’s teammates in the Kobe University rugby club said, “[Yamanaka] was not a smart player, but his technique was good and he was able to keep the other team from stealing the ball. He was a serious student, and returned to his classes as soon as practice ended.”

During a press conference, Yamanaka was asked what place he thought he would be in if he was running a marathon. “I’d be in the middle, ” he said.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy